RecruitingNCT07675161

MiniMed Fit Payload Wear Pediatric Study

CIP361: MiniMed Fit Payload Wear Pediatric Study


Sponsor

Medtronic MiniMed, Inc.

Enrollment

100 participants

Start Date

Jun 25, 2026

Study Type

OBSERVATIONAL

Conditions

Summary

The purpose of this study is to assess MiniMed Fit Payload adhesive components in different wear locations over a 7-day period to support development of the future commercialized patch pump in participants 7-17 years of age.


Eligibility

Min Age: 7 YearsMax Age: 17 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called MiniMed Fit Payload adhesive components for people with diabetes (dm), diabetes (insulin-requiring, type 1 or type 2), and other related conditions. The study is currently recruiting participants at 3 locations. People eligible for this study include aged 7 Years to 17 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEMiniMed Fit Payload adhesive components

The MiniMed Fit Payload device used in this study will be made of polycarbonate materials, will not contain any electronic or mechanical components, and is intended to mimic the shape and weight of a future product. Each device will consist of the payload assembly and an adhesive patch, which will be adhered to the payload on one side and the subject's skin on the other.


Locations(5)

Sutter Institute for Medical Research

Sacramento, California, United States

Sansum Diabetes Research Institute

Santa Barbara, California, United States

Rocky Mountain Clinical Research

Idaho Falls, Idaho, United States

Barry J Reiner MD LLC

Baltimore, Maryland, United States

Diabetes and Glandular Disease Clinic PA

San Antonio, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07675161


Related Trials